141 related articles for article (PubMed ID: 32512047)
1. Minimal Clinically Important Differences and Feasibility of Dyspnea-12 and the Multidimensional Dyspnea Profile in Cardiorespiratory Disease.
Ekström MP; Bornefalk H; Sköld CM; Janson C; Blomberg A; Bornefalk-Hermansson A; Igelström H; Sandberg J; Sundh J
J Pain Symptom Manage; 2020 Nov; 60(5):968-975.e1. PubMed ID: 32512047
[TBL] [Abstract][Full Text] [Related]
2. Validation of the Swedish Multidimensional Dyspnea Profile (MDP) in outpatients with cardiorespiratory disease.
Ekström M; Bornefalk H; Sköld M; Janson C; Blomberg A; Sandberg J; Bornefalk-Hermansson A; Igelström H; Sundh J
BMJ Open Respir Res; 2019; 6(1):e000381. PubMed ID: 31681476
[TBL] [Abstract][Full Text] [Related]
3. Clinical validation of the Swedish version of Dyspnoea-12 instrument in outpatients with cardiorespiratory disease.
Sundh J; Bornefalk H; Sköld CM; Janson C; Blomberg A; Sandberg J; Bornefalk-Hermansson A; Igelström H; Ekström M
BMJ Open Respir Res; 2019; 6(1):e000418. PubMed ID: 31673362
[TBL] [Abstract][Full Text] [Related]
4. Validation of the Dyspnoea-12 and Multidimensional Dyspnea profile among older Swedish men in the population.
Olsson M; Ekström M
BMC Geriatr; 2022 Jun; 22(1):477. PubMed ID: 35655151
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of completing Multidimensional Dyspnea Profile and Dyspnea-12 over the telephone in patients with oxygen-dependent disease.
Bech TW; Eklund M; Spaak E; Palm A; Ekström M
BMJ Open Respir Res; 2021 Nov; 8(1):. PubMed ID: 34836925
[TBL] [Abstract][Full Text] [Related]
6. How to Assess Breathlessness in Chronic Obstructive Pulmonary Disease.
Lewthwaite H; Jensen D; Ekström M
Int J Chron Obstruct Pulmon Dis; 2021; 16():1581-1598. PubMed ID: 34113091
[TBL] [Abstract][Full Text] [Related]
7. Minimal clinically important differences in average, best, worst and current intensity and unpleasantness of chronic breathlessness.
Ekström M; Johnson MJ; Huang C; Currow DC
Eur Respir J; 2020 Aug; 56(2):. PubMed ID: 32341113
[TBL] [Abstract][Full Text] [Related]
8. Outcome measurement of refractory breathlessness: endpoints and important differences.
Ekström M; Currow DC; Johnson MJ
Curr Opin Support Palliat Care; 2015 Sep; 9(3):238-43. PubMed ID: 26203849
[TBL] [Abstract][Full Text] [Related]
9. Dyspnoea-12 and Multidimensional Dyspnea Profile: Systematic Review of Use and Properties.
Williams MT; Lewthwaite H; Paquet C; Johnston K; Olsson M; Belo LF; Pitta F; Morelot-Panzini C; Ekström M
J Pain Symptom Manage; 2022 Jan; 63(1):e75-e87. PubMed ID: 34273524
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and severity of differing dimensions of breathlessness among elderly males in the population.
Olsson M; Currow DC; Johnson MJ; Sandberg J; Engström G; Ekström M
ERJ Open Res; 2022 Jan; 8(1):. PubMed ID: 35141316
[TBL] [Abstract][Full Text] [Related]
11. Real-life assessment of the multidimensional nature of dyspnoea in COPD outpatients.
Morélot-Panzini C; Gilet H; Aguilaniu B; Devillier P; Didier A; Perez T; Pignier C; Arnould B; Similowski T
Eur Respir J; 2016 Jun; 47(6):1668-79. PubMed ID: 27076585
[TBL] [Abstract][Full Text] [Related]
12. Minimal Clinically Important Difference in Barthel Index Dyspnea in Patients with COPD.
Vitacca M; Malovini A; Balbi B; Aliani M; Cirio S; Spanevello A; Fracchia C; Maniscalco M; Corica G; Ambrosino N; Paneroni M
Int J Chron Obstruct Pulmon Dis; 2020; 15():2591-2599. PubMed ID: 33116476
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the Dyspnoea-12 and Multidimensional Dyspnoea Profile in people with COPD.
Williams MT; John D; Frith P
Eur Respir J; 2017 Mar; 49(3):. PubMed ID: 28182565
[TBL] [Abstract][Full Text] [Related]
14. Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Fatigue in Patients With COPD Following Pulmonary Rehabilitation.
Rebelo P; Oliveira A; Andrade L; Valente C; Marques A
Chest; 2020 Aug; 158(2):550-561. PubMed ID: 32184112
[TBL] [Abstract][Full Text] [Related]
15. Breathlessness dimensions association with physical and mental quality of life: the population based VASCOL study of elderly men.
Cristea L; Olsson M; Currow D; Johnson M; Sandberg J; Ekström M
BMJ Open Respir Res; 2021 Nov; 8(1):. PubMed ID: 34740943
[TBL] [Abstract][Full Text] [Related]
16. Which breathlessness dimensions associate most strongly with fatigue?-The population-based VASCOL study of elderly men.
Cristea L; Olsson M; Sandberg J; Kochovska S; Currow D; Ekström M
PLoS One; 2023; 18(12):e0296016. PubMed ID: 38117831
[TBL] [Abstract][Full Text] [Related]
17. A breath of fresh air: Validity and reliability of a Portuguese version of the Multidimensional Dyspnea Profile for patients with COPD.
Belo LF; Rodrigues A; Vicentin AP; Paes T; de Castro LA; Hernandes NA; Pitta F
PLoS One; 2019; 14(4):e0215544. PubMed ID: 31039167
[TBL] [Abstract][Full Text] [Related]
18. Automated Oxygen Administration Alleviates Dyspnea in Patients Admitted with Acute Exacerbation of COPD: A Randomized Controlled Trial.
Sandau C; Hansen EF; Ringbæk TJ; Kallemose T; Bove DG; Poulsen I; Nørholm V; Pedersen L; Jensen JUS; Ulrik CS
Int J Chron Obstruct Pulmon Dis; 2023; 18():599-614. PubMed ID: 37096159
[TBL] [Abstract][Full Text] [Related]
19. Linguistic Validation of the Japanese Version of the Multidimensional Dyspnea Profile and Relation to Physical Activity in Patients with COPD.
Kanezaki M; Tamaki A; Terada K; Ebihara S
Int J Chron Obstruct Pulmon Dis; 2022; 17():223-230. PubMed ID: 35087271
[TBL] [Abstract][Full Text] [Related]
20. Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD.
Rebelo P; Oliveira A; Paixão C; Valente C; Andrade L; Marques A
Int J Chron Obstruct Pulmon Dis; 2020; 15():201-212. PubMed ID: 32099345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
